Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3076)
All Articles published online
|
Dec 21, 2006 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Koishi K, Yoshikawa R, Tsujimura T, Hashimoto-Tamaoki T, Kojima S, Yanagi H, Yamamura T, Fujiwara Y. Persistent CXCR4 expression after preoperative chemoradiotherapy predicts early recurrence and poor prognosis in esophageal cancer. World J Gastroenterol 2006; 12(47): 7585-7590 [PMID: 17171785 DOI: 10.3748/wjg.v12.i47.7585] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i47/7585.htm |
| Number | Citing Articles |
| 1 |
Albert Zlotnik, Amanda M. Burkhardt, Bernhard Homey. Homeostatic chemokine receptors and organ-specific metastasis. Nature Reviews Immunology 2011; 11(9): 597 doi: 10.1038/nri3049
|
| 2 |
Sebastian Di Cesare, Jean-Claude Marshall, Bruno F Fernandes, Patrick Logan, Emilia Antecka, Vasco Bravo Filho, Miguel N Burnier. In vitro characterization and inhibition of the CXCR4/CXCL12 chemokine axis in human uveal melanoma cell lines. Cancer Cell International 2007; 7(1) doi: 10.1186/1475-2867-7-17
|
| 3 |
Ji-Kun Li, Liang Yu, Yun Shen, Li-Sheng Zhou, Yi-Cheng Wang, Jian-Hai Zhang. Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells <italic>in vitro</italic>. World Journal of Gastroenterology 2008; 14(15): 2308-2313 doi: 10.3748/wjg.14.2308
|
| 4 |
Masakazu Goto, Mingyao Liu. Chemokines and their receptors as biomarkers in esophageal cancer. Esophagus 2020; 17(2): 113 doi: 10.1007/s10388-019-00706-8
|
| 5 |
Qingtao Jiang, Yun Sun, Xin Liu. CXCR4 as a prognostic biomarker in gastrointestinal cancer: a meta-analysis. Biomarkers 2019; 24(6): 510 doi: 10.1080/1354750X.2019.1637941
|
| 6 |
|
| 7 |
Lingyun Wei, Nang Yan, Lei Sun, Chuanen Bao, Demin Li. Interplay between the NF‑κB and hedgehog signaling pathways predicts prognosis in esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3447
|
| 8 |
Philipp Linde, Christian Baues, Simone Wegen, Maike Trommer, Alexander Quaas, Johannes Rosenbrock, Eren Celik, Simone Marnitz, Christiane J. Bruns, Thomas Fischer, Klaus Schomaecker, Hans-Juergen Wester, Alexander Drzezga, Lutz van Heek, Carsten Kobe. Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer – a first clinical approach. Cancer Imaging 2021; 21(1) doi: 10.1186/s40644-021-00391-w
|
| 9 |
Ajaz A. Bhat, Sabah Nisar, Selma Maacha, Tatiana Correa Carneiro-Lobo, Sabah Akhtar, Kodappully Sivaraman Siveen, Nissar A. Wani, Arshi Rizwan, Puneet Bagga, Mayank Singh, Ravinder Reddy, Shahab Uddin, Jean-Charles Grivel, Gyan Chand, Michael P. Frenneaux, Mushtaq A. Siddiqi, Davide Bedognetti, Wael El-Rifai, Muzafar A. Macha, Mohammad Haris. Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy. Molecular Cancer 2021; 20(1) doi: 10.1186/s12943-020-01294-3
|
| 10 |
R Yoshikawa, Y Nakano, L Tao, K Koishi, T Matsumoto, M Sasako, T Tsujimura, T Hashimoto-Tamaoki, Y Fujiwara. Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy. British Journal of Cancer 2008; 98(10): 1670 doi: 10.1038/sj.bjc.6604361
|
| 11 |
Ines Gockel, Carl C Schimanski, Markus Moehler, Theodor Junginger. Novel therapeutic targets in esophageal cancer: impact of chemokine receptor CXCR4. Future Oncology 2007; 3(2): 119 doi: 10.2217/14796694.3.2.119
|
| 12 |
Takuya Akashi, Keiichi Koizumi, Koichi Tsuneyama, Ikuo Saiki, Yasuo Takano, Hideki Fuse. Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer. Cancer Science 2008; 99(3): 539 doi: 10.1111/j.1349-7006.2007.00712.x
|
| 13 |
B Song, Y Wang, Y Xi, K Kudo, S Bruheim, G I Botchkina, E Gavin, Y Wan, A Formentini, M Kornmann, O Fodstad, J Ju. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 2009; 28(46): 4065 doi: 10.1038/onc.2009.274
|
| 14 |
Verbeke Hannelien, Geboes Karel, Van Damme Jo, Struyf Sofie. The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2012; 1825(1): 117 doi: 10.1016/j.bbcan.2011.10.008
|
| 15 |
Bungo Furusato, Ahmed Mohamed, Mathias Uhlén, Johng S. Rhim. CXCR4 and cancer. Pathology International 2010; 60(7): 497 doi: 10.1111/j.1440-1827.2010.02548.x
|
| 16 |
Purvaba J. Sarvaiya, Donna Guo, Ilya Ulasov, Patrik Gabikian, Maciej S. Lesniak. Chemokines in tumor progression and metastasis. Oncotarget 2013; 4(12): 2171 doi: 10.18632/oncotarget.1426
|
| 17 |
Seok Jin Jung, Chun Il Kim, Choal Hee Park, Hyuk Soo Chang, Byung Hoon Kim, Mi Sun Choi, Hyea Ra Jung. Correlation between Chemokine Receptor CXCR4 Expression and Prognostic Factors in Patients with Prostate Cancer. Korean Journal of Urology 2011; 52(9): 607 doi: 10.4111/kju.2011.52.9.607
|
| 18 |
Wenchao Zhang, Xudong Wang, Kai Yue, Su Liu, Xiaonan Liu. Construction of a CXCL12-KDEL Fusion Gene to Inhibit Head and Neck Squamous Cell Carcinoma Metastasis by Intracellular Sequestration of CXCR4. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/195828
|
| 19 |
Benjamin Terfa Igbo, Annett Linge, Susanne Frosch, Theresa Suckert, Liane Stolz-Kieslich, Steffen Löck, Mani Sankari Kumaravadivel, Thilo Welsch, Jürgen Weitz, Ulrich Sommer, Daniela Aust, Esther G.C. Troost. Immunohistochemical analyses of paraffin-embedded sections after primary surgery or trimodality treatment in esophageal carcinoma. Clinical and Translational Radiation Oncology 2022; 36: 106 doi: 10.1016/j.ctro.2022.08.001
|
| 20 |
Wei Li, Weidong Zhao, Zhaohui Lu, Wen Zhang, Xuan Yang. Long Noncoding RNA GAS5 Promotes Proliferation, Migration, and Invasion by Regulation of miR-301a in Esophageal Cancer. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2018; 26(8): 1285 doi: 10.3727/096504018X15166193231711
|
| 21 |
Bungo Furusato, Johng S. Rhim. Chemokine Receptors in Cancer. 2009; : 31 doi: 10.1007/978-1-60327-267-4_2
|
| 22 |
Dao-feng Wang, Ning Lou, Xiao-dong Li, Zhang Xu, An-guang Zeng, Yong-bin Lin. Effect of lentivirus-induced shRNA silencing CXCR4 gene on proliferation and apoptosis in human esophageal carcinoma cell line Eca109. Clinical Oncology and Cancer Research 2010; 7(3): 193 doi: 10.1007/s11805-010-0517-9
|
| 23 |
Jia Wang, Jing Cai, Fang Han, Chun Yang, Qiaoling Tong, Ting Cao, Liying Wu, Zehua Wang. Silencing of CXCR4 Blocks Progression of Ovarian Cancer and Depresses Canonical Wnt Signaling Pathway. International Journal of Gynecological Cancer 2011; 21(6): 981 doi: 10.1097/IGC.0b013e31821d2543
|
| 24 |
Pei Chen, Yu-Ling Zhang, Xiao-Lei Zhang, Ying Guo, Pei-Pei Tang. The CXCR4 might be a potential biomarker for esophageal squamous cell carcinoma: A meta-analysis. Medicine 2024; 103(14): e37681 doi: 10.1097/MD.0000000000037681
|
| 25 |
Shuang Zou, Dongchen Zhang, Zhongwei Xu, Xiaochang Wen, Yan Zhang. JMJD3 promotes the epithelial‑mesenchymal transition and migration of glioma cells via the CXCL12/CXCR4 axis. Oncology Letters 2019; doi: 10.3892/ol.2019.10972
|
| 26 |
Hongli Zhao, Liyuan Guo, Hong Zhao, Jiaxin Zhao, Hao Weng, Bin Zhao. CXCR4 over-expression and survival in cancer: A system review and meta-analysis. Oncotarget 2015; 6(7): 5022 doi: 10.18632/oncotarget.3217
|
| 27 |
Hye-Rim Park, Jinwon Seo, Patrizia Bacchini, Franco Bertoni, Yong-Koo Park. Differential Expression of CXCR4 in Conventional High-grade and Low-grade Central Osteosarcoma and Its Prognostic Implications. The Journal of the Korean Bone and Joint Tumor Society 2012; 18(1): 20 doi: 10.5292/jkbjts.2012.18.1.20
|
| 28 |
Reigetsu Yoshikawa, Tohru Tsujimura, Lihua Tao, Norihiko Kamikonya, Yoshinori Fujiwara. The oncoprotein and stem cell renewal factor BMI1 associates with poor clinical outcome in oesophageal cancer patients undergoing preoperative chemoradiotherapy. BMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-461
|
| 29 |
Tao Yu, Yingying Wu, Joseph I. Helman, Yuming Wen, Changmei Wang, Longjiang Li. CXCR4 Promotes Oral Squamous Cell Carcinoma Migration and Invasion through Inducing Expression of MMP-9 and MMP-13 via the ERK Signaling Pathway. Molecular Cancer Research 2011; 9(2): 161 doi: 10.1158/1541-7786.MCR-10-0386
|
| 30 |
T L Mao, K F Fan, C L Liu. Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer. Gene Therapy 2017; 24(10): 621 doi: 10.1038/gt.2017.69
|
| 31 |
Xiaoqing Yang, Qingyang Lu, Yunfei Xu, Can Liu, Qing Sun. Clinicopathologic significance of CXCR4 expressions in patients with esophageal squamous cell carcinoma. Pathology - Research and Practice 2020; 216(1): 152787 doi: 10.1016/j.prp.2019.152787
|
| 32 |
Hyunsuk Shim, Shinya Oishi, Nobutaka Fujii. Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors. Seminars in Cancer Biology 2009; 19(2): 123 doi: 10.1016/j.semcancer.2008.11.004
|
| 33 |
Xingwei Wang, Yan Cao, Shirong Zhang, Zhihui Chen, Ling Fan, Xiaochun Shen, Shiwen Zhou, Dongfeng Chen. Stem cell autocrine CXCL12/CXCR4 stimulates invasion and metastasis of esophageal cancer. Oncotarget 2017; 8(22): 36149 doi: 10.18632/oncotarget.15254
|
| 34 |
Mina Alimohammadi, Ali Rahimi, Fatemeh Faramarzi, Reza Alizadeh-Navaei, Alireza Rafiei. Overexpression of chemokine receptor CXCR4 predicts lymph node metastatic risk in patients with melanoma: A systematic review and meta-analysis. Cytokine 2021; 148: 155691 doi: 10.1016/j.cyto.2021.155691
|